Table 3 Drugs used for rheumatoid arthritis treatment in the population of the REAL study [19]
Variables (n = 1116) | n (%) |
|---|---|
Glucocorticoids | 529 (47.4) |
Dose ≥10 mg (n = 527) | 82/527 (15.6) |
Non-steroidal anti-inflammatory | 743 (66.6) |
Methotrexate | 742 (66.5) |
Leflunomide | 378 (33.9) |
Antimalarials (chloroquine/hydroxychloroquine) | 146 (13.1) |
Sulfasalazine | 55 (4.9) |
Tofacitinib | 9 (0.8) |
Biologicals | 398 (35.7) |
Anti-TNF (adalimumab, infliximab, etanercept, certolizumab, golimumab) | 222 (19.9) |
Anti-IL6r (tocilizumab) | 55 (4.9) |
Abatacept | 72 (6.5) |
Rituximab | 49 (4.4) |